Cargando…

C/EBPα: critical at the origin of leukemic transformation

Acute myeloid leukemia (AML) is a hematopoietic malignancy characterized by clonal expansion of myeloid progenitor cells. A major mechanistic theme in AML biology is the extensive collaboration among fusion oncoproteins, transcription factors, and chromatin regulators to initiate and sustain a trans...

Descripción completa

Detalles Bibliográficos
Autores principales: Roe, Jae-Seok, Vakoc, Christopher R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892974/
https://www.ncbi.nlm.nih.gov/pubmed/24395889
http://dx.doi.org/10.1084/jem.20132530
_version_ 1782299615146541056
author Roe, Jae-Seok
Vakoc, Christopher R.
author_facet Roe, Jae-Seok
Vakoc, Christopher R.
author_sort Roe, Jae-Seok
collection PubMed
description Acute myeloid leukemia (AML) is a hematopoietic malignancy characterized by clonal expansion of myeloid progenitor cells. A major mechanistic theme in AML biology is the extensive collaboration among fusion oncoproteins, transcription factors, and chromatin regulators to initiate and sustain a transformed cellular state. A new study in this issue describes how the C/EBPα transcription factor is crucial for the initiation of AML induced by MLL fusion oncoproteins, but is entirely dispensable for the maintenance of established disease. These observations provide a unique glimpse into the pioneer round of regulatory events that are critical at the origin of AML formation. Furthermore, this study implies the existence of oncogene-induced positive feedback loops capable of bypassing the continuous need for certain regulators to propagate disease.
format Online
Article
Text
id pubmed-3892974
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-38929742014-07-13 C/EBPα: critical at the origin of leukemic transformation Roe, Jae-Seok Vakoc, Christopher R. J Exp Med Minireview Acute myeloid leukemia (AML) is a hematopoietic malignancy characterized by clonal expansion of myeloid progenitor cells. A major mechanistic theme in AML biology is the extensive collaboration among fusion oncoproteins, transcription factors, and chromatin regulators to initiate and sustain a transformed cellular state. A new study in this issue describes how the C/EBPα transcription factor is crucial for the initiation of AML induced by MLL fusion oncoproteins, but is entirely dispensable for the maintenance of established disease. These observations provide a unique glimpse into the pioneer round of regulatory events that are critical at the origin of AML formation. Furthermore, this study implies the existence of oncogene-induced positive feedback loops capable of bypassing the continuous need for certain regulators to propagate disease. The Rockefeller University Press 2014-01-13 /pmc/articles/PMC3892974/ /pubmed/24395889 http://dx.doi.org/10.1084/jem.20132530 Text en © 2014 Roe and Vakoc This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).
spellingShingle Minireview
Roe, Jae-Seok
Vakoc, Christopher R.
C/EBPα: critical at the origin of leukemic transformation
title C/EBPα: critical at the origin of leukemic transformation
title_full C/EBPα: critical at the origin of leukemic transformation
title_fullStr C/EBPα: critical at the origin of leukemic transformation
title_full_unstemmed C/EBPα: critical at the origin of leukemic transformation
title_short C/EBPα: critical at the origin of leukemic transformation
title_sort c/ebpα: critical at the origin of leukemic transformation
topic Minireview
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892974/
https://www.ncbi.nlm.nih.gov/pubmed/24395889
http://dx.doi.org/10.1084/jem.20132530
work_keys_str_mv AT roejaeseok cebpacriticalattheoriginofleukemictransformation
AT vakocchristopherr cebpacriticalattheoriginofleukemictransformation